$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Transdermal nitroglycerin in cirrhosis. A 24-hour echo-Doppler study of splanchnic hemodynamics

Journal of hepatology : the journal of the European Association for the Study of the Liver, v.25 no.4, 1996년, pp.498 - 503  

Zoli, M. (Instituto di Clinica Medica Generale e Terapia Medica, University of Bologna, ,, Bologna, Italy) ,  Magalotti, D. ,  Ghigi, G. ,  Marchesini, G. ,  Pisi, E.

Abstract AI-Helper 아이콘AI-Helper

Background/Aims: The present study was aimed to evaluate the 24-hour effect of transdermal nitroglycerin on splanchnic hemodynamics in cirrhotic patients.Methods: Hemodynamic parameters (blood velocity and resistance indexes) were determined by means of pulsed echo-Doppler, a non-invasive method whi...

참고문헌 (35)

  1. Ann Int Med Pagliaro 117 59 1992 10.7326/0003-4819-117-1-59 Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment 

  2. J Gastroenterol Hepatol Gibson 1 201 1986 10.1111/j.1440-1746.1986.tb00114.x The hypotensive effect of oral nitroglycerin on portal venous pressure in patients with cirrhotic portan hypertension 

  3. Hepatology Zoli 6 1248 1986 10.1002/hep.1840060604 Portal venous flow in response to acute β-blocker and vasodilatatory treatment in patients with liver cirrhosis 

  4. Hepatology Garcia-Tsao 7 805 1987 10.1002/hep.1840070502 Portal hemodynamics during nitroglycerin administration in cirrhotic patients 

  5. Hepatology Blei 9 896 1989 10.1002/hep.1840090618 Vasodilator therapy of portal hypertension: focus on the liver 

  6. J Hepatol Mols 8 316 1989 10.1016/0168-8278(89)90029-9 Systemic and regional hemodynamic effects of isosorbide dinitrate in patients with liver cirrhosis and portal hypertension 

  7. Gastroenterology Navasa 96 110 1989 10.1016/0016-5085(89)91630-2 Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis 

  8. Am J Gastroenterol Jones 89 7 1994 Organic nitrates in portal hypertension 

  9. Hepatology Vorobioff 3 477 1993 10.1002/hep.1840180302 Propanolol compared with propanolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects 

  10. Gastroenterology Angelico 104 1460 1993 10.1016/0016-5085(93)90356-H Isosorbide-5-mononitrate versus propanolol in the prevention of first bleeding in cirrhosis 

  11. J Ultrasound Med Bolognesi 13 945 1994 10.7863/jum.1994.13.12.945 Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients 

  12. Hepatology Iwao 13 124 1991 10.1002/hep.1840130118 Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis 

  13. Gastroenterology Sabba 102 1002 1992 10.1016/0016-5085(92)90190-A A randomized study of propanolol on post-prandial portal hyperemia in cirrhotic patients 

  14. Br J Surg Pugh 60 646 1973 10.1002/bjs.1800600817 Transection of the oesophagus for bleeding oesophageal varices 

  15. Gastrointest Endosc Beppu 27 213 1981 10.1016/S0016-5107(81)73224-3 Prediction of variceal hemorrhage by esophageal endoscopy 

  16. Hepatology Sabba 21 428 1995 Inter-observer and inter-equipment variability of echo-Doppler examination of the portal vein: effect of a cooperative training program 

  17. J Ultrasound Med Zoli 15 99 1996 10.7863/jum.1996.15.2.99 Interobserver and inter-equipment variability of echo-Doppler sonographic evaluation of the superior mesenteric artery 

  18. J Clin Ultrasound Zoli 14 429 1986 10.1002/jcu.1870140605 Echo-Doppler measurement of splanchnic blood flow in control and cirrhotic subjects 

  19. J Clin Ultrasound Nakamura 17 261 1989 10.1002/jcu.1870170406 Quantitative measurement of abdominal arterial blood flow using image-directed Doppler ultrasonography: superior mesenteric, splenic, and common hepatic arterial blood flow in normal adults 

  20. Hepatology Blei 5 264 1985 10.1002/hep.1840050219 Pharmacokinetic-hemodynamic interactions between vasopressin and nitroglycerin: comparison between intravenous and cutaneous routes of nitrate delivery 

  21. Gastroenterology Blei 86 1428 1984 10.1016/S0016-5085(84)80155-9 Portal-systemic shunting and hemodynamic effects of nitroglycerin in the rat 

  22. Am J Gastroenterol Saraya 88 1850 1993 Effects of intravenous nitroglycerin and metoclopramide on intravariceal pressure: a double blind, randomized study 

  23. Am J Gastroenterol Alison 89 7 1994 Organic nitrates in portal hypertension 

  24. J Hepatol Grose 20 542 1994 10.1016/S0168-8278(05)80503-3 The acute and chronic effects of isosorbide-5-mononitrate on portal haemodynamics in cirrhosis 

  25. J Hepatol Barbara 10 353 1990 10.1016/0168-8278(90)90146-I The value of Doppler US in the study of hepatic hemodynamics. Consensus conference 

  26. J Ultrasound Med Sabba 9 705 1990 10.7863/jum.1990.9.12.705 Feasibility spectrum for Doppler flowmetry of splanchnic vessels in normal and cirrhotic populations 

  27. Hepatology S 9 815 1989 10.1002/hep.1840090604 Effect of meal on portal hemodynamics in healthy humans and in patients with chronic liver disease 

  28. Hepatology Sabba 4 714 1991 10.1002/hep.1840130417 Evaluation of postprandial hyperemia in superior mesenteric artery and portal vein in healthy and cirrhotic humans: an operator-blind echo-Doppler study 

  29. Hepatology Alvarez 5 1198 1994 10.1002/hep.1840200515 Diurnal fluctuations of portal and systemic hemodynamic parameters in patients with cirrhosis 

  30. Gastroenterol Clin North Am Rodriguez-Perez 21 15 1992 10.1016/S0889-8553(21)00176-X Pharmacological treatment of portal hypertension 

  31. Gut Hayes 29 752 1988 10.1136/gut.29.6.752 Effect and mechanism of action of isosorbide-5-mononitrate 

  32. Federation Proc Richardson 41 2111 1982 Physiological regulation of the hepatic circulation 

  33. Hepatology Salmeron 17 800 1993 Renal effects of acute isosorbide-5-mononitrate administration in cirrhosis 

  34. J Hepatol Garcia-Pagan 11 189 1990 10.1016/0168-8278(90)90112-5 Long-term haemodynamic effects of isosorbide-5-mononitrate in patients with cirrhosis and portal hypertension 

  35. J Cardiovasc Pharmacol Henry 14 31 1989 10.1097/00005344-198907000-00007 Determinants of in vitro nitroglycerin tolerance induction and reversal: influence of dose regimen, nitrate-free period and sulphydryl supplementation 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로